Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.220
-0.100 (-2.31%)
At close: Dec 5, 2025, 4:00 PM EST
4.241
+0.021 (0.51%)
After-hours: Dec 5, 2025, 7:24 PM EST
Pyxis Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 263 | 93 | 80 | 47 | 353 | - | |
| Market Cap Growth | 6.22% | 16.32% | 70.77% | -86.78% | - | - | |
| Enterprise Value | 206 | -32 | -32 | -136 | 414 | - | |
| Last Close Price | 4.22 | 1.56 | 1.80 | 1.34 | 10.97 | - | |
| PS Ratio | 92.33 | 5.75 | - | - | - | - | |
| PB Ratio | 3.81 | 0.77 | 0.63 | 0.29 | 1.35 | - | |
| P/TBV Ratio | 3.96 | 0.79 | 0.79 | 0.29 | 1.35 | - | |
| Debt / Equity Ratio | 0.28 | 0.17 | 0.17 | 0.12 | 0.00 | 0.12 | |
| Asset Turnover | 0.02 | 0.10 | - | - | - | - | |
| Quick Ratio | 3.93 | 7.18 | 4.63 | 5.69 | 14.69 | 2.19 | |
| Current Ratio | 4.29 | 7.49 | 4.84 | 5.90 | 14.90 | 2.20 | |
| Return on Equity (ROE) | -87.28% | -62.76% | -51.51% | -57.19% | -56.78% | -101.15% | |
| Return on Assets (ROA) | -34.33% | -24.77% | -26.10% | -31.41% | -30.03% | -53.80% | |
| Return on Capital (ROIC) | -39.41% | -28.46% | -30.76% | -34.98% | -32.45% | -61.61% | |
| Return on Capital Employed (ROCE) | -95.80% | -47.00% | -54.30% | -68.70% | -26.70% | -199.50% | |
| Earnings Yield | -36.95% | -83.36% | -92.53% | -258.50% | -21.50% | - | |
| FCF Yield | -27.54% | -62.42% | -97.10% | -205.00% | -10.15% | - | |
| Buyback Yield / Dilution | -13.72% | -46.46% | -20.80% | -288.93% | -724.14% | -53.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.